Navigating the Crossroads: Cardiometabolic Risks in Cancer Survivorship - a Comprehensive Review

Overview

Journal Cardiooncology

Publisher Biomed Central

Specialty Oncology

Date 2024 Jun 15

PMID 38879583

Authors

Arif Albulushi

Aisha Al Balushi

Muhhamed Shahzad

Ismail Al Bulushi

Hatim Al Lawati

Affiliations

Soon will be listed here.

Abstract

The landscape of cancer survivorship is increasingly populated by individuals facing a spectrum of cardiometabolic risks, attributed to both their oncological history and treatment regimens. This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors-hypertension, dyslipidemia, diabetes-as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. Through a lens of multidisciplinary management and future research directives, we advocate for an integrative approach to cardiometabolic health in cancer survivors, aiming to ensure their victory over cancer extends into long-term well-being.

Citing Articles

Retraction Note: Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review.

Albulushi A, Al Balushi A, Shahzad M, Al Bulushi I, Al Lawati H Cardiooncology. 2025; 11(1):6.

PMID: 39849640 PMC: 11756185. DOI: 10.1186/s40959-025-00306-9.

References

Gent D, Rebecca D . The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus. Eur Cardiol. 2023; 18:e16. PMC: 10316349. DOI: 10.15420/ecr.2022.63. View

Misiag W, Piszczyk A, Szymanska-Chabowska A, Chabowski M . Physical Activity and Cancer Care-A Review. Cancers (Basel). 2022; 14(17). PMC: 9454950. DOI: 10.3390/cancers14174154. View

Giovannucci E, Harlan D, Archer M, Bergenstal R, Gapstur S, Habel L . Diabetes and cancer: a consensus report. Diabetes Care. 2010; 33(7):1674-85. PMC: 2890380. DOI: 10.2337/dc10-0666. View

Romero S, Jones L, Bauml J, Li Q, Cohen R, Mao J . The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer. 2018; 26(10):3423-3430. PMC: 6117206. DOI: 10.1007/s00520-018-4203-4. View

Herrmann J . Vascular toxic effects of cancer therapies. Nat Rev Cardiol. 2020; 17(8):503-522. PMC: 8782612. DOI: 10.1038/s41569-020-0347-2. View

Simon M, Hastert T, Barac A, Banack H, Caan B, Chlebowski R . Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. Cancer. 2020; 127(4):598-608. PMC: 10448774. DOI: 10.1002/cncr.33295. View

Miller K, Nogueira L, Devasia T, Mariotto A, Yabroff K, Jemal A . Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022; 72(5):409-436. DOI: 10.3322/caac.21731. View

Keaver L, OCallaghan N, Douglas P . Nutrition support and intervention preferences of cancer survivors. J Hum Nutr Diet. 2022; 36(2):526-539. DOI: 10.1111/jhn.13058. View

Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A . Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014; 106(9). PMC: 4176042. DOI: 10.1093/jnci/dju232. View

10.

Patel S, Suero-Abreu G, Ai A, Ramachandran M, Meza K, Florez N . Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations. Front Oncol. 2023; 13:1124447. PMC: 10289233. DOI: 10.3389/fonc.2023.1124447. View

11.

de Haas E, Oosting S, Lefrandt J, Wolffenbuttel B, Sleijfer D, Gietema J . The metabolic syndrome in cancer survivors. Lancet Oncol. 2010; 11(2):193-203. DOI: 10.1016/S1470-2045(09)70287-6. View

12.

Diab A, Dastmalchi L, Gulati M, Michos E . A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?. Vasc Health Risk Manag. 2023; 19:237-253. PMC: 10128075. DOI: 10.2147/VHRM.S379874. View

13.

Campbell K, Winters-Stone K, Wiskemann J, May A, Schwartz A, Courneya K . Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019; 51(11):2375-2390. PMC: 8576825. DOI: 10.1249/MSS.0000000000002116. View

14.

Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M . Chronic Stress Promotes Cancer Development. Front Oncol. 2020; 10:1492. PMC: 7466429. DOI: 10.3389/fonc.2020.01492. View

15.

Chiefari E, Mirabelli M, La Vignera S, Tanyolac S, Foti D, Aversa A . Insulin Resistance and Cancer: In Search for a Causal Link. Int J Mol Sci. 2021; 22(20). PMC: 8540232. DOI: 10.3390/ijms222011137. View

16.

Barre P, Padmaja G, Rana S, Tiamongla . Stress and Quality of Life in Cancer Patients: Medical and Psychological Intervention. Indian J Psychol Med. 2018; 40(3):232-238. PMC: 5968644. DOI: 10.4103/IJPSYM.IJPSYM_512_17. View

17.

Mouhayar E, Salahudeen A . Hypertension in cancer patients. Tex Heart Inst J. 2011; 38(3):263-5. PMC: 3113122. View

18.

Liu E, Suthahar N, Paniagua S, Wang D, Lau E, Li S . Association of Cardiometabolic Disease With Cancer in the Community. JACC CardioOncol. 2022; 4(1):69-81. PMC: 9040108. DOI: 10.1016/j.jaccao.2022.01.095. View

19.

Koene R, Prizment A, Blaes A, Konety S . Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016; 133(11):1104-14. PMC: 4800750. DOI: 10.1161/CIRCULATIONAHA.115.020406. View

20.

Bhatnagar R, Dixit N, Yang E, Sallam T . Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues. Front Cardiovasc Med. 2022; 9:925816. PMC: 9396263. DOI: 10.3389/fcvm.2022.925816. View